Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:807-819
Published online before print August 14, 2006, doi: 10.1161/CIRCULATIONAHA.105.602359
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
114/8/807    most recent
CIRCULATIONAHA.105.602359v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barlic, J.
Right arrow Articles by Murphy, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barlic, J.
Right arrow Articles by Murphy, P. M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LINOLEIC ACID
Related Collections
Right arrow Lipids
Right arrow Lipid and lipoprotein metabolism
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Pathophysiology
Right arrow Cell biology/structural biology
Right arrow Cell signalling/signal transduction
Right arrow Gene regulation
Right arrow Growth factors/cytokines

(Circulation. 2006;114:807-819.)
© 2006 American Heart Association, Inc.


Molecular Cardiology

Oxidized Lipid-Driven Chemokine Receptor Switch, CCR2 to CX3CR1, Mediates Adhesion of Human Macrophages to Coronary Artery Smooth Muscle Cells Through a Peroxisome Proliferator-Activated Receptor {gamma}–Dependent Pathway

Jana Barlic, PhD; Yuan Zhang; John F. Foley, PhD; Philip M. Murphy, MD

From the Molecular Signaling Section (J.B., Y.Z., P.M.M.) and Inflammation Biology Section (J.F.F.), Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.

Correspondence to Philip M. Murphy, MD, 9000 Rockville Pike, Bldg 10, Room 11N113, NIH, Bethesda, MD 20892. E-mail pmm{at}nih.gov

Received November 18, 2005; revision received June 14, 2006; accepted June 19, 2006.

Background— Recent genetic data in mouse and humans suggest that the chemokine receptors CCR2 and CX3CR1 are involved in atherogenesis; however, detailed molecular and cellular mechanisms have not been fully delineated.

Methods and Results— Here, we show that oxidized linoleic acid metabolites, which are components of oxidized LDL found in large amounts in atherosclerotic plaque, were able to specifically induce differentiation of human monocytes to macrophages with decreased expression of CCR2, confirming a previous report, and increased expression of CX3CR1. These macrophages acquired the ability to adhere to coronary artery smooth muscle cells. The adhesion was mediated directly and predominantly by CX3CR1. Reciprocal effects of these lipids on CCR2 and CX3CR1 expression were mediated by the nuclear receptor peroxisome proliferator-activated receptor (PPAR) {gamma}, and targeting the PPAR{gamma} gene with sRNAi dramatically reduced macrophage adhesion to coronary artery smooth muscle cells.

Conclusions— These data suggest that in atherogenesis oxidized lipid-driven activation of macrophage PPAR{gamma} in the intima may result in a proadhesive chemokine receptor switch–CCR2 off, CX3CR1 on–causing cessation of CCR2-dependent migration and activation of CX3CR1-dependent retention mechanisms, which together promote macrophage accumulation in vessel wall. Our results may explain at the molecular and cell biology levels the genetic link between CX3CR1 and atherosclerosis. Moreover, they identify macrophage binding to coronary artery smooth muscle cells as the first primary cell setting in which CX3CR1 functions as the major adhesion system.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. C. Doran, N. Meller, and C. A. McNamara
Role of Smooth Muscle Cells in the Initiation and Early Progression of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 812 - 819.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Saederup, L. Chan, S. A. Lira, and I. F. Charo
Fractalkine Deficiency Markedly Reduces Macrophage Accumulation and Atherosclerotic Lesion Formation in CCR2-/- Mice: Evidence for Independent Chemokine Functions in Atherogenesis
Circulation, April 1, 2008; 117(13): 1642 - 1648.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Combadiere, S. Potteaux, M. Rodero, T. Simon, A. Pezard, B. Esposito, R. Merval, A. Proudfoot, A. Tedgui, and Z. Mallat
Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6Chi and Ly6Clo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice
Circulation, April 1, 2008; 117(13): 1649 - 1657.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Lu, L. Li, K. Kuno, Y. Wu, T. Baba, Y.-y. Li, X. Zhang, and N. Mukaida
Protective Roles of the Fractalkine/CX3CL1-CX3CR1 Interactions in Alkali-Induced Corneal Neovascularization through Enhanced Antiangiogenic Factor Expression
J. Immunol., March 15, 2008; 180(6): 4283 - 4291.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Cuzzocrea, S. Bruscoli, E. Mazzon, C. Crisafulli, V. Donato, R. Di Paola, E. Velardi, E. Esposito, G. Nocentini, and C. Riccardi
Peroxisome Proliferator-Activated Receptor-{alpha} Contributes to the Anti-Inflammatory Activity of Glucocorticoids
Mol. Pharmacol., February 1, 2008; 73(2): 323 - 337.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. J. Kim, S. A. Ham, S. U. Kim, J.-Y. Hwang, J.-H. Kim, K. C. Chang, C. Yabe-Nishimura, J.-H. Kim, and H. G. Seo
Transforming Growth Factor-{beta}1 Is a Molecular Target for the Peroxisome Proliferator-Activated Receptor {delta}
Circ. Res., February 1, 2008; 102(2): 193 - 200.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. Lucchinetti, J. Aguirre, J. Feng, M. Zhu, M. Suter, D. R. Spahn, L. Harter, and M. Zaugg
Molecular Evidence of Late Preconditioning After Sevoflurane Inhalation in Healthy Volunteers
Anesth. Analg., September 1, 2007; 105(3): 629 - 640.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Barlic and P. M. Murphy
Chemokine regulation of atherosclerosis
J. Leukoc. Biol., August 1, 2007; 82(2): 226 - 236.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Barlic, Y. Zhang, and P. M. Murphy
Atherogenic Lipids Induce Adhesion of Human Coronary Artery Smooth Muscle Cells to Macrophages by Up-regulating Chemokine CX3CL1 on Smooth Muscle Cells in a TNF{alpha}-NF{kappa}B-dependent Manner
J. Biol. Chem., June 29, 2007; 282(26): 19167 - 19176.
[Abstract] [Full Text] [PDF]